IBANDRONATE SODIUM TAB

IBANDRONATE SODIUM TAB: IBANDRONATE SODIUM TAB, also known by its brand name Boniva, is a medication used to treat and prevent osteoporosis in postmenopausal women. It belongs to a class of drugs called bisphosphonates.

The main mechanism of action of Ibandronate Sodium is the inhibition of bone resorption, which helps prevent bone loss and strengthens existing bone. It works by specifically binding to bone tissue and inhibiting the activity of osteoclasts, the cells responsible for breaking down bone.

The usual recommended dose of Ibandronate Sodium is 150 mg tablet once monthly. It should be taken orally on an empty stomach, at least 1 hour before or 2 hours after eating or drinking anything other than plain water. It is important to follow the specific dosing instructions provided by the healthcare provider.

Like any medication, Ibandronate Sodium may have some side effects. The most common side effects include indigestion, diarrhea, stomach pain, muscle or joint pain, and headache. Some individuals may also experience a rare but serious side effect known as osteonecrosis of the jaw, which is the death of bone tissue in the jaw. Symptoms may include jaw pain, swelling, numbness, or infection. Other rare but serious side effects include unusual thigh bone fractures and low calcium levels.

It is important to discuss the potential risks and benefits of Ibandronate Sodium with a healthcare provider before starting the medication. They can provide personalized recommendations and monitor for any potential side effects.